{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:38:04Z","timestamp":1791329884368,"version":"4.3.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,16]],"date-time":"2010-01-16T00:00:00Z","timestamp":1263600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s12149-009-0330-9","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T10:46:54Z","timestamp":1263552414000},"page":"55-66","source":"Crossref","is-referenced-by-count":35,"title":["Amyloid-plaque imaging in early and differential diagnosis of dementia"],"prefix":"10.1007","volume":"24","author":[{"given":"Alexander","family":"Drzezga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,16]]},"reference":[{"key":"330_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","volume":"34","author":"J Zaccai","year":"2005","unstructured":"Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34:561\u20136.","journal-title":"Age Ageing"},{"key":"330_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.1992.tb04447.x","volume":"139","author":"I Alafuzoff","year":"1992","unstructured":"Alafuzoff I. The pathology of dementias: an overview. Acta Neurol Scand Suppl. 1992;139:8\u201315.","journal-title":"Acta Neurol Scand Suppl"},{"issue":"Suppl 3","key":"330_CR3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00002093-199912001-00004","volume":"13","author":"H Aguero-Torres","year":"1999","unstructured":"Aguero-Torres H, Winblad B, Fratiglioni L. Epidemiology of vascular dementia: some results despite research limitations. Alzheimer Dis Assoc Disord. 1999;13(Suppl 3):S15\u201320.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"330_CR4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jalz.2008.05.2479","volume":"4","author":"K Ziegler-Graham","year":"2008","unstructured":"Ziegler-Graham K, Brookmeyer R, Johnson E, Arrighi HM. Worldwide variation in the doubling time of Alzheimer\u2019s disease incidence rates. Alzheimers Dement. 2008;4:316\u201323.","journal-title":"Alzheimers Dement"},{"key":"330_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2000-10858","volume":"62","author":"H Bickel","year":"2000","unstructured":"Bickel H. Dementia syndrome and Alzheimer disease: an assessment of morbidity and annual incidence in Germany. Gesundheitswesen. 2000;62:211\u20138.","journal-title":"Gesundheitswesen"},{"key":"330_CR6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","volume":"60","author":"LE Hebert","year":"2003","unstructured":"Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119\u201322.","journal-title":"Arch Neurol"},{"issue":"9533","key":"330_CR7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H. Alzheimer\u2019s disease. Lancet. 2006;368(9533):387\u2013403.","journal-title":"Lancet"},{"key":"330_CR8","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association. 2008 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2008;4:110\u201333.","DOI":"10.1016\/j.jalz.2008.02.005"},{"key":"330_CR9","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association. 2009 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2009;5(3):27\u201331.","DOI":"10.1016\/j.jalz.2009.03.001"},{"key":"330_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000109998","volume":"29","author":"BL Plassman","year":"2007","unstructured":"Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29:125\u201332.","journal-title":"Neuroepidemiology"},{"issue":"6968","key":"330_CR11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02264","volume":"426","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe DJ. Folding proteins in fatal ways. Nature. 2003;426(6968):900\u20134.","journal-title":"Nature"},{"issue":"Suppl 3","key":"330_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00014168","volume":"249","author":"E Braak","year":"1999","unstructured":"Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H. Neuropathology of Alzheimer\u2019s disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci. 1999;249(Suppl 3):14\u201322.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"5054","key":"330_CR13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"key":"330_CR14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192:106\u201313.","journal-title":"Behav Brain Res"},{"key":"330_CR15","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2165\/00003495-200666160-00004","volume":"66","author":"M Hull","year":"2006","unstructured":"Hull M, Berger M, Heneka M. Disease-modifying therapies in Alzheimer\u2019s disease: how far have we come? Drugs. 2006;66:2075\u201393.","journal-title":"Drugs"},{"key":"330_CR16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/PL00014176","volume":"249","author":"H Forstl","year":"1999","unstructured":"Forstl H, Kurz A. Clinical features of Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci. 1999;249:288\u201390.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"330_CR17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"330_CR18","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.38.11.1688","volume":"38","author":"L Davies","year":"1988","unstructured":"Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, et al. A4 amyloid protein deposition and the diagnosis of Alzheimer\u2019s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology. 1988;38:1688\u201393.","journal-title":"Neurology"},{"key":"330_CR19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","volume":"56","author":"DS Knopman","year":"2001","unstructured":"Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143\u201353.","journal-title":"Neurology"},{"key":"330_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183\u201394.","journal-title":"J Intern Med"},{"key":"330_CR21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/jnnp.2003.015032","volume":"75","author":"E Arnaiz","year":"2004","unstructured":"Arnaiz E, Almkvist O, Ivnik RJ, Tangalos EG, Wahlund LO, Winblad B, et al. Mild cognitive impairment: a cross-national comparison. J Neurol Neurosurg Psychiatry. 2004;75:1275\u201380.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"330_CR22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303\u20138.","journal-title":"Arch Neurol"},{"key":"330_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1212\/01.wnl.0000228244.10416.20","volume":"67","author":"PA Boyle","year":"2006","unstructured":"Boyle PA, Wilson RS, Aggarwal NT, Tang Y, Bennett DA. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology. 2006;67:441\u20135.","journal-title":"Neurology"},{"key":"330_CR24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jocn.2004.03.011","volume":"12","author":"VL Villemagne","year":"2005","unstructured":"Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer\u2019s disease. J Clin Neurosci. 2005;12:221\u201330.","journal-title":"J Clin Neurosci"},{"key":"330_CR25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000256697.20968.d7","volume":"68","author":"DP Devanand","year":"2007","unstructured":"Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology. 2007;68:828\u201336.","journal-title":"Neurology"},{"key":"330_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1212\/01.wnl.0000287091.57376.65","volume":"70","author":"AS Fleisher","year":"2008","unstructured":"Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology. 2008;70:191\u20139.","journal-title":"Neurology"},{"key":"330_CR27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/01.wnl.0000180958.22678.91","volume":"65","author":"CR Jack Jr","year":"2005","unstructured":"Jack CR Jr, Shiung MM, Weigand SD, O\u2019Brien PC, Gunter JL, Boeve BF, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005;65:1227\u201331.","journal-title":"Neurology"},{"key":"330_CR28","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1532-5415.2008.01684.x","volume":"56","author":"ML Ries","year":"2008","unstructured":"Ries ML, Carlsson CM, Rowley HA, Sager MA, Gleason CE, Asthana S, et al. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc. 2008;56:920\u201334.","journal-title":"J Am Geriatr Soc"},{"key":"330_CR29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.rmr.0000245463.36148.12","volume":"16","author":"LO Wahlund","year":"2005","unstructured":"Wahlund LO, Almkvist O, Blennow K, Engedahl K, Johansson A, Waldemar G, et al. Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup. Top Magn Reson Imag. 2005;16:427\u201337.","journal-title":"Top Magn Reson Imag"},{"key":"330_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","volume":"10","author":"K Shoghi-Jadid","year":"2002","unstructured":"Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry. 2002;10:24\u201335.","journal-title":"Am J Geriatr Psychiatry"},{"key":"330_CR31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306\u201319.","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"330_CR32","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s00259-007-0705-x","volume":"35","author":"G Henriksen","year":"2008","unstructured":"Henriksen G, Yousefi BH, Drzezga A, Wester HJ. Development and evaluation of compounds for imaging of beta-amyloid plaque by means of positron emission tomography. Eur J Nucl Med Mol Imag. 2008;35(Suppl 1):S75\u201381.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"330_CR33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.drudis.2006.10.008","volume":"11","author":"A Lockhart","year":"2006","unstructured":"Lockhart A. Imaging Alzheimer\u2019s disease pathology: one target, many ligands. Drug Discov Today. 2006;11:1093\u20139.","journal-title":"Drug Discov Today"},{"key":"330_CR34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-4159.2009.05996.x","volume":"109","author":"PW Thompson","year":"2009","unstructured":"Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, et al. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer\u2019s disease pathologies. J Neurochem. 2009;109:623\u201330.","journal-title":"J Neurochem"},{"key":"330_CR35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2967\/jnumed.108.056499","volume":"50","author":"N Tolboom","year":"2009","unstructured":"Tolboom N, Yaqub M, van der Flier WM, Boellaard R, Luurtsema G, Windhorst AD, et al. Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. J Nucl Med. 2009;50:191\u20137.","journal-title":"J Nucl Med"},{"key":"330_CR36","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"KE Pike","year":"2007","unstructured":"Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer\u2019s disease. Brain. 2007;130:2837\u201344.","journal-title":"Brain"},{"key":"330_CR37","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","volume":"27","author":"WE Klunk","year":"2007","unstructured":"Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci. 2007;27:6174\u201384.","journal-title":"J Neurosci"},{"key":"330_CR38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/brain\/awn107","volume":"131","author":"J Koivunen","year":"2008","unstructured":"Koivunen J, Verkkoniemi A, Aalto S, Paetau A, Ahonen JP, Viitanen M, et al. PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer\u2019s disease. Brain. 2008;131:1845\u201353.","journal-title":"Brain"},{"key":"330_CR39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.106.037762","volume":"48","author":"S Ng","year":"2007","unstructured":"Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, et al. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer\u2019s disease. J Nucl Med. 2007;48:547\u201352.","journal-title":"J Nucl Med"},{"key":"330_CR40","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","volume":"286","author":"DH Silverman","year":"2001","unstructured":"Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001;286:2120\u20137.","journal-title":"JAMA"},{"key":"330_CR41","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain. 2008;131:1630\u201345.","journal-title":"Brain"},{"key":"330_CR42","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","volume":"65","author":"V Leinonen","year":"2008","unstructured":"Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Nagren K, et al. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol. 2008;65:1304\u20139.","journal-title":"Arch Neurol"},{"key":"330_CR43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2009.01.027","volume":"65","author":"T Grimmer","year":"2009","unstructured":"Grimmer T, Riemenschneider M, Forstl H, Henriksen G, Klunk WE, Mathis CA, et al. Beta amyloid in Alzheimer\u2019s disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Biol Psychiatry. 2009;65:927\u201334.","journal-title":"Biol Psychiatry"},{"key":"330_CR44","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","volume":"29","author":"A Forsberg","year":"2008","unstructured":"Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging. 2008;29:1456\u201365.","journal-title":"Neurobiol Aging"},{"key":"330_CR45","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","volume":"132","author":"EC Mormino","year":"2009","unstructured":"Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain. 2009;132:1310\u201323.","journal-title":"Brain"},{"key":"330_CR46","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","volume":"25","author":"JC Price","year":"2005","unstructured":"Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab. 2005;25:1528\u201347.","journal-title":"J Cereb Blood Flow Metab"},{"key":"330_CR47","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349\u201356.","journal-title":"JAMA"},{"key":"330_CR48","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2009;106:6820\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"330_CR49","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.0b013e3181a2e8d0","volume":"72","author":"A Drzezga","year":"2009","unstructured":"Drzezga A, Grimmer T, Henriksen G, Muhlau M, Perneczky R, Miederer I, et al. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology. 2009;72:1487\u201394.","journal-title":"Neurology"},{"key":"330_CR50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 2006;67:446\u201352.","journal-title":"Neurology"},{"key":"330_CR51","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","volume":"46","author":"VL Villemagne","year":"2008","unstructured":"Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, et al. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer\u2019s disease. Neuropsychologia. 2008;46:1688\u201397.","journal-title":"Neuropsychologia"},{"key":"330_CR52","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","volume":"65","author":"HJ Aizenstein","year":"2008","unstructured":"Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65:1509\u201317.","journal-title":"Arch Neurol"},{"key":"330_CR53","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/brain\/awm191","volume":"130","author":"A Lockhart","year":"2007","unstructured":"Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, et al. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain. 2007;130:2607\u201315.","journal-title":"Brain"},{"key":"330_CR54","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1471-4159.2008.05245.x","volume":"105","author":"L Ye","year":"2008","unstructured":"Ye L, Velasco A, Fraser G, Beach TG, Sue L, Osredkar T, et al. In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain. J Neurochem. 2008;105:1428\u201337.","journal-title":"J Neurochem"},{"key":"330_CR55","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1523\/JNEUROSCI.0630-07.2007","volume":"27","author":"MT Fodero-Tavoletti","year":"2007","unstructured":"Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, et al. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J Neurosci. 2007;27:10365\u201371.","journal-title":"J Neurosci"},{"key":"330_CR56","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","volume":"355","author":"GW Small","year":"2006","unstructured":"Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med. 2006;355:2652\u201363.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"330_CR57","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/s00259-007-0697-6","volume":"35","author":"A Drzezga","year":"2008","unstructured":"Drzezga A. Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies. Eur J Nucl Med Mol Imag. 2008;35(Suppl 1):S4\u201311.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"330_CR58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF02988628","volume":"16","author":"K Ishii","year":"2002","unstructured":"Ishii K. Clinical application of positron emission tomography for diagnosis of dementia. Ann Nucl Med. 2002;16:515\u201325.","journal-title":"Ann Nucl Med"},{"key":"330_CR59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","volume":"69","author":"D Weisman","year":"2007","unstructured":"Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology. 2007;69:356\u20139.","journal-title":"Neurology"},{"key":"330_CR60","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","volume":"71","author":"SN Gomperts","year":"2008","unstructured":"Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, et al. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008;71:903\u201310.","journal-title":"Neurology"},{"key":"330_CR61","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","volume":"68","author":"CC Rowe","year":"2007","unstructured":"Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging beta-amyloid burden in aging and dementia. Neurology. 2007;68:1718\u201325.","journal-title":"Neurology"},{"key":"330_CR62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.64.3.431","volume":"64","author":"BJ Bacskai","year":"2007","unstructured":"Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, et al. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol. 2007;64:431\u20134.","journal-title":"Arch Neurol"},{"key":"330_CR63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02988444","volume":"17","author":"K Herholz","year":"2003","unstructured":"Herholz K. PET studies in dementia. Ann Nucl Med. 2003;17:79\u201389.","journal-title":"Ann Nucl Med"},{"key":"330_CR64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O\u2019Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305\u201313.","journal-title":"Lancet Neurol"},{"key":"330_CR65","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000077151","volume":"17","author":"M Ikeda","year":"2004","unstructured":"Ikeda M, Ishikawa T, Tanabe H. Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2004;17:265\u20138.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"Suppl 1","key":"330_CR66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051209","volume":"10","author":"JS Snowden","year":"1999","unstructured":"Snowden JS. Semantic dysfunction in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 1999;10(Suppl 1):33\u20136.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"330_CR67","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546\u201354.","journal-title":"Neurology"},{"issue":"5796","key":"330_CR68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133.","journal-title":"Science"},{"key":"330_CR69","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-005-1079-4","volume":"110","author":"J Shi","year":"2005","unstructured":"Shi J, Shaw CL, Du Plessis D, Richardson AM, Bailey KL, Julien C, et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol (Berl). 2005;110:501\u201312.","journal-title":"Acta Neuropathol (Berl)"},{"key":"330_CR70","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/brain\/awh582","volume":"128","author":"RR Davies","year":"2005","unstructured":"Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH. The pathological basis of semantic dementia. Brain. 2005;128:1984\u201395.","journal-title":"Brain"},{"key":"330_CR71","first-page":"925","volume":"62","author":"JK Johnson","year":"2005","unstructured":"Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, et al. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol. 2005;62:925\u201330.","journal-title":"Arch Neurol"},{"key":"330_CR72","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00259-007-0523-1","volume":"35","author":"H Engler","year":"2008","unstructured":"Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, et al. In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imag. 2008;35:100\u20136.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"330_CR73","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/01.wnl.0000259035.98480.ed","volume":"68","author":"GD Rabinovici","year":"2007","unstructured":"Rabinovici GD, Furst AJ, O\u2019Neil JP, Racine CA, Mormino EC, Baker SL, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2007;68:1205\u201312.","journal-title":"Neurology"},{"key":"330_CR74","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","volume":"39","author":"A Drzezga","year":"2008","unstructured":"Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, et al. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer\u2019s disease. Neuroimage. 2008;39:619\u201333.","journal-title":"Neuroimage"},{"key":"330_CR75","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.21451","volume":"64","author":"GD Rabinovici","year":"2008","unstructured":"Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol. 2008;64:388\u2013401.","journal-title":"Ann Neurol"},{"key":"330_CR76","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1023\/B:NERE.0000023612.66691.e6","volume":"29","author":"M Sadowski","year":"2004","unstructured":"Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, et al. Links between the pathology of Alzheimer\u2019s disease and vascular dementia. Neurochem Res. 2004;29:1257\u201366.","journal-title":"Neurochem Res"},{"key":"330_CR77","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","volume":"62","author":"KA Johnson","year":"2007","unstructured":"Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol. 2007;62:229\u201334.","journal-title":"Ann Neurol"},{"key":"330_CR78","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archneur.65.4.540","volume":"65","author":"AM Remes","year":"2008","unstructured":"Remes AM, Laru L, Tuominen H, Aalto S, Kemppainen N, Mononen H, et al. Carbon 11-labeled Pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication. Arch Neurol. 2008;65:540\u20134.","journal-title":"Arch Neurol"},{"key":"330_CR79","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","volume":"129","author":"H Engler","year":"2006","unstructured":"Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease. Brain. 2006;129:2856\u201366.","journal-title":"Brain"},{"key":"330_CR80","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.neurobiolaging.2008.01.016","volume":"30","author":"T Grimmer","year":"2009","unstructured":"Grimmer T, Henriksen G, Wester HJ, Forstl H, Klunk WE, Mathis CA, et al. Clinical severity of Alzheimer\u2019s disease is associated with PIB uptake in PET. Neurobiol Aging. 2009;30:1902\u20139.","journal-title":"Neurobiol Aging"},{"key":"330_CR81","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ana.21345","volume":"63","author":"A Kadir","year":"2008","unstructured":"Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, et al. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer\u2019s disease. Ann Neurol. 2008;63:621\u201331.","journal-title":"Ann Neurol"},{"key":"330_CR82","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1196\/annals.1379.012","volume":"1097","author":"MJ Leon de","year":"2007","unstructured":"de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer\u2019s disease. Ann N Y Acad Sci. 2007;1097:114\u201345.","journal-title":"Ann N Y Acad Sci"},{"key":"330_CR83","first-page":"1625","volume":"46","author":"A Drzezga","year":"2005","unstructured":"Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med. 2005;46:1625\u201332.","journal-title":"J Nucl Med"},{"key":"330_CR84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/156720506776383103","volume":"3","author":"PJ Modrego","year":"2006","unstructured":"Modrego PJ. Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Curr Alzheimer Res. 2006;3:161\u201370.","journal-title":"Curr Alzheimer Res"},{"key":"330_CR85","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","volume":"63","author":"L Mosconi","year":"2004","unstructured":"Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, et al. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology. 2004;63:2332\u201340.","journal-title":"Neurology"},{"key":"330_CR86","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.090106797","volume":"97","author":"GW Small","year":"2000","unstructured":"Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2000;97:6037\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"330_CR87","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00259-005-0050-x","volume":"33","author":"T Kawachi","year":"2006","unstructured":"Kawachi T, Ishii K, Sakamoto S, Sasaki M, Mori T, Yamashita F, et al. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer\u2019s disease. Eur J Nucl Med Mol Imag. 2006;33:801\u20139.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"330_CR88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuroimage.2008.10.053","volume":"45","author":"KB Walhovd","year":"2009","unstructured":"Walhovd KB, Fjell AM, Amlien I, Grambaite R, Stenset V, Bjornerud A, et al. Multimodal imaging in mild cognitive impairment: metabolism, morphometry and diffusion of the temporal-parietal memory network. Neuroimage. 2009;45:215\u201323.","journal-title":"Neuroimage"},{"key":"330_CR89","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","volume":"131","author":"CR Jack Jr","year":"2008","unstructured":"Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer\u2019s disease and amnestic mild cognitive impairment. Brain. 2008;131:665\u201380.","journal-title":"Brain"},{"key":"330_CR90","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","volume":"35","author":"Y Li","year":"2008","unstructured":"Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imag. 2008;35:2169\u201381.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"330_CR91","first-page":"1968","volume":"47","author":"C Catana","year":"2006","unstructured":"Catana C, Wu Y, Judenhofer MS, Qi J, Pichler BJ, Cherry SR. Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. J Nucl Med. 2006;47:1968\u201376.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-009-0330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-009-0330-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-009-0330-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T20:19:52Z","timestamp":1590524392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-009-0330-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,16]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["330"],"URL":"https:\/\/doi.org\/10.1007\/s12149-009-0330-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,16]]}}}